Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1423-0127

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway ; volume:26 ; number:1 ; day:5 ; month:12 ; year:2019 ; pages:1-13 ; date:12.2019
Journal of biomedical science ; 26, Heft 1 (5.12.2019), 1-13, 12.2019

Creator: Wakabayashi, Grace
Lee, Yu-Ching
Luh, Frank
Kuo, Chun-Nan
Chang, Wei-Chiao
Yen, Yun

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12929-019-0588-8

URN: urn:nbn:de:101:1-2020032708262540722531

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wakabayashi, Grace
Lee, Yu-Ching
Luh, Frank
Kuo, Chun-Nan
Chang, Wei-Chiao
Yen, Yun
SpringerLink (Online service)

Other Objects (12)

Correction to: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

PD-L1 degradation pathway and immunotherapy for cancer

Cancer immunotherapies targeting the PD-1 signaling pathway

The Notch signaling pathway: a potential target for cancer immunotherapy

PD-L1 inhibitors in cancer immunotherapy : exploring the principles of PD-L1/PD-1 pathway inhibition in the treatment of cancer

Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling

Beyond PD-1 Immunotherapy in Malignant Melanoma

Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

Correction to: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

PD-L1 degradation pathway and immunotherapy for cancer

Cancer immunotherapies targeting the PD-1 signaling pathway

The Notch signaling pathway: a potential target for cancer immunotherapy

PD-L1 inhibitors in cancer immunotherapy : exploring the principles of PD-L1/PD-1 pathway inhibition in the treatment of cancer

Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling

Beyond PD-1 Immunotherapy in Malignant Melanoma

Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

Correction to: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

PD-L1 degradation pathway and immunotherapy for cancer

Cancer immunotherapies targeting the PD-1 signaling pathway

The Notch signaling pathway: a potential target for cancer immunotherapy

PD-L1 inhibitors in cancer immunotherapy : exploring the principles of PD-L1/PD-1 pathway inhibition in the treatment of cancer

Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling

Beyond PD-1 Immunotherapy in Malignant Melanoma

Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Correction to: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

PD-L1 degradation pathway and immunotherapy for cancer

Cancer immunotherapies targeting the PD-1 signaling pathway

The Notch signaling pathway: a potential target for cancer immunotherapy

PD-L1 inhibitors in cancer immunotherapy : exploring the principles of PD-L1/PD-1 pathway inhibition in the treatment of cancer

Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling

Beyond PD-1 Immunotherapy in Malignant Melanoma

Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

Correction to: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

PD-L1 degradation pathway and immunotherapy for cancer

Cancer immunotherapies targeting the PD-1 signaling pathway

The Notch signaling pathway: a potential target for cancer immunotherapy

PD-L1 inhibitors in cancer immunotherapy : exploring the principles of PD-L1/PD-1 pathway inhibition in the treatment of cancer

Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling

Beyond PD-1 Immunotherapy in Malignant Melanoma

Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

Correction to: Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

PD-L1 degradation pathway and immunotherapy for cancer

Cancer immunotherapies targeting the PD-1 signaling pathway

The Notch signaling pathway: a potential target for cancer immunotherapy

PD-L1 inhibitors in cancer immunotherapy : exploring the principles of PD-L1/PD-1 pathway inhibition in the treatment of cancer

Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling

Beyond PD-1 Immunotherapy in Malignant Melanoma

Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

Related objects

Reset password